Bio-Path Holdings, Inc. (NASDAQ:BPTH – Free Report) – Roth Capital boosted their Q2 2024 earnings per share estimates for Bio-Path in a report released on Wednesday, May 15th. Roth Capital analyst J. Aschoff now forecasts that the company will post earnings per share of ($2.06) for the quarter, up from their previous estimate of ($4.60). […]